Company Review Biologicals & Immunologicals: Biogen: Will cell surface markers pave the way?

Expert Opinion on Therapeutic Patents

Volumn 6, Issue 12, 1996, Pages 1261-1266

  Thomas, Sandy m ^a   Burke, Julian F ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004859820     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.6.12.1261     Document Type: Article

References (5)

1. THOMAS SM, BURKE JF: Genentech in the 1990s: takingrecombinant therapeutics to market. Exp. Opin. Ther, Patents 6 (10): 973 – 981.
2. THOMAS SM, BURICE JF: Amgen picks the genes thatmake a winner. Exp. Opin. Then Patents (1996) 6 (11): 1139 – 1145.
3. OFFICE OF TECHNOLOGY ASSESSMENT (OTA): Biotech-nology in a Global Economy. OTA, Washington (1992).
4. ANON: Fulfilling the Promise of Biotechnology. Biogen Annual Report (1995).
5. DICKSON D: British ruling supports legal challenges to broad patents. Nature (1996) 384: 7.